🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study includes two parts:Part 1: SSGJ-707 (different dosing regimens) ...
Status
Recruiting
Location
Liu Tianshu
Start Date
2024-09-03
Trial ID
NCT06493760
Treatments Being Tested
This phase II trial studies how well giving bevacizumab, radiation therapy,...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2006-07-25
Trial ID
NCT00321685
The purpose of this research study is to look at how tumors responds to a s...
Status
Completed
Location
Washington University School of Medicine
Start Date
2016-05-27
Trial ID
NCT02641691
Treatments Being Tested
This open-label, prospective, single-arm, multicenter study will evaluate t...
Status
Completed
Location
Canberra Hospital
Start Date
2012-06-26
Trial ID
NCT01588990
Treatments Being Tested
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-12
Trial ID
NCT03167177
This 4 arm study assessed the efficacy and safety of oral capecitabine (Xel...
Status
Completed
Location
Multiple Locations
Start Date
2003-07
Trial ID
NCT00069095
Drugs used in chemotherapy, such as oxaliplatin, leucovorin, fluorouracil, ...
Status
Terminated
Location
Southwest Oncology Group
Start Date
2004-04
Trial ID
NCT00070122
This study is designed to evaluate the efficacy and safety of adjuvant hype...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2016-11
Trial ID
NCT02965248
The goal of this clinical trial is to establish guidelines for fluoropyrimi...
Status
Recruiting
Location
CHU Amiens
Start Date
2025-01-20
Trial ID
NCT06475352
Treatments Being Tested
The combination of oxaliplatin, 5-FU, leucovorin, and capecitabine is hypot...
Status
Completed
Location
University of Wisconsin
Start Date
2004-04
Trial ID
NCT00205322
Treatments Being Tested